
GW Pharmaceuticals plc Retained Earnings 2011-2025 | GWPH
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
 - debt repayment
 - acquisition of other companies
 - creation of reserves for the future
 
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings GW Pharmaceuticals plc
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 
|---|---|---|---|---|---|---|---|---|---|
| -896 M | -838 M | -757 M | -399 M | -232 M | -187 M | -132 M | -111 M | -105 M | -107 M | 
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average | 
|---|---|---|
| -105 M | -896 M | -376 M | 
Retained Earnings of other stocks in the Drug manufacturers industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
| 
              
              Amryt Pharma plc
               AMYT 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -236 M | $ 14.7 | - | $ 621 M | ||
| 
              
              Aerie Pharmaceuticals
               AERI 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -1.15 B | $ 15.25 | - | $ 754 M | ||
| 
              
              PetIQ
               PETQ 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -161 M | $ 13.6 | 1.64 % | $ 400 M | ||
| 
              
              Agile Therapeutics
               AGRX 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -423 M | $ 0.6 | 10.11 % | $ 58.2 M | ||
| 
              
              Teligent, Inc.
               TLGT 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -121 M | $ 0.173 | -13.85 % | $ 16.1 M | ||
| 
              
              Recro Pharma
               REPH 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -279 M | $ 1.4 | -4.76 % | $ 65.3 M | ||
| 
              
              Athenex
               ATNX 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -1.02 B | $ 0.2 | -23.39 % | $ 1.76 M | ||
| 
              
              PLx Pharma 
               PLXP 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -148 M | $ 0.09 | -27.8 % | $ 2.56 M | ||
| 
              
              Shineco, Inc.
               TYHT 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    44.3 M | $ 11.09 | -3.90 % | $ 97.2 M | ||
| 
              
              Organogenesis Holdings 
               ORGO 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -40.1 M | $ 3.96 | -6.82 % | $ 521 M | ||
| 
              
              Lannett Company
               LCI 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -596 M | $ 0.66 | 1.15 % | $ 7.11 M | ||
| 
              
              Perrigo Company plc
               PRGO 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -2.25 B | $ 20.5 | -1.16 % | $ 2.82 B | ||
| 
              
              ProPhase Labs
               PRPH 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    11.8 M | $ 0.32 | -11.52 % | $ 5.07 M | ||
| 
              
              Calliditas Therapeutics AB (publ)
               CALT 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -1.43 B | $ 40.0 | -0.1 % | $ 2.03 B | ||
| 
              
              Adamas Pharmaceuticals, Inc.
               ADMS 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -505 M | $ 8.22 | - | $ 376 M | ||
| 
              
              Dr. Reddy's Laboratories Limited
               RDY 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    156 B | $ 13.43 | 0.98 % | $ 2.23 B | ||
| 
              
              Flexion Therapeutics, Inc.
               FLXN 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -782 M | $ 9.12 | - | $ 459 M | ||
| 
              
              Happiness Biotech Group Limited
               HAPP 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    12.3 M | $ 4.5 | 1.35 % | $ 17.8 M | ||
| 
              
              Kindred Biosciences, Inc.
               KIN 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -245 M | $ 9.25 | 0.11 % | $ 419 M | ||
| 
              
              Supernus Pharmaceuticals
               SUPN 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    556 M | $ 56.0 | 1.57 % | $ 3.09 B | ||
| 
              
              China SXT Pharmaceuticals
               SXTC 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -28 M | $ 1.42 | - | $ 2.02 M | ||
| 
              
              Neos Therapeutics, Inc.
               NEOS 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -334 M | $ 1.15 | -2.54 % | $ 57.2 M | ||
| 
              
              Endo International plc
               ENDP 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -15.4 B | $ 0.29 | - | $ 28.9 M | ||
| 
              
              Teva Pharmaceutical Industries Limited
               TEVA 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -15.2 B | $ 20.63 | 0.68 % | $ 23.3 B | ||
| 
              
              Tricida
               TCDA 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -810 M | $ 0.11 | - | $ 3.25 M | ||
| 
              
              Tilray
               TLRY 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -2.42 B | $ 1.31 | -2.38 % | $ 810 M | ||
| 
              
              PPD, Inc.
               PPD 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -2.27 B | $ 47.25 | 0.13 % | $ 16.6 B | ||
| 
              
              Bausch Health Companies 
               BHC 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -9.78 B | $ 6.87 | -2.35 % | $ 2.51 B | ||
| 
              
              HEXO Corp.
               HEXO 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -659 M | $ 0.71 | 2.45 % | $ 38.1 M | - | |
| 
              
              Veru 
               VERU 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -295 M | $ 2.57 | -12.88 % | $ 347 M | ||
| 
              
              Neptune Wellness Solutions 
               NEPT 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -164 M | $ 0.2 | -45.3 % | $ 917 K | ||
| 
              
              Viatris 
               VTRS 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    5.18 B | $ 10.55 | 1.79 % | $ 12.8 B | ||
| 
              
              Taro Pharmaceutical Industries Ltd.
               TARO 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    2.39 B | $ 42.97 | - | $ 1.62 B | ||
| 
              
              Horizon Therapeutics Public Limited Company
               HZNP 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    590 M | $ 116.3 | - | $ 26.6 B | ||
| 
              
              FSD Pharma 
               HUGE 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -90.9 M | $ 5.84 | 5743.5 % | $ 69.7 M | ||
| 
              
              Adamis Pharmaceuticals Corporation
               ADMP 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -305 M | $ 0.78 | 0.86 % | $ 117 M | ||
| 
              
              Zynerba Pharmaceuticals
               ZYNE 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -275 M | $ 1.3 | - | $ 55.5 M | ||
| 
              
              Guardion Health Sciences
               GHSI 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -93.7 M | $ 3.25 | -0.31 % | $ 3.64 M | ||
| 
              
              Alimera Sciences
               ALIM 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -418 M | $ 5.54 | - | $ 142 M | ||
| 
              
              Biogen 
               BIIB 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    19.3 B | $ 152.15 | -1.37 % | $ 22.2 B | ||
| 
              
              Qilian International Holding Group Limited
               QLI 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    14.7 M | $ 5.41 | -6.08 % | $ 184 M | ||
| 
              
              Amneal Pharmaceuticals
               AMRX 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -607 M | $ 5.91 | 2.6 % | $ 892 M | - | |
| 
              
              Ironwood Pharmaceuticals
               IRWD 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -1.7 B | $ 1.88 | -2.08 % | $ 299 M | ||
| 
              
              Avadel Pharmaceuticals plc
               AVDL 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -794 M | $ 18.86 | -0.13 % | $ 1.79 B | ||
| 
              
              Cumberland Pharmaceuticals 
               CPIX 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -24 M | $ 2.69 | -9.17 % | $ 37.8 M | ||
| 
              
              Aurora Cannabis
               ACB 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -3.59 B | $ 4.88 | -1.41 % | $ 86.3 M | - | |
| 
              
              Eagle Pharmaceuticals
               EGRX 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    112 M | $ 2.14 | -39.89 % | $ 27.7 M | ||
| 
              
              OrganiGram Holdings 
               OGI 
              
             | 
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                    -145 M | $ 1.59 | -2.16 % | $ 402 M |